Please provide your email address to receive an email when new articles are posted on . Device-based therapy may be necessary for certain patients with NYHA class II/III heart failure with reduced ...
SAN FRANCISCO, CA, UNITED STATES, September 24, 2025 /EINPresswire.com/ -- RhythmScience, a leader in cardiac data management solutions, today announced it has ...
NICE has given the go-ahead for the use of two algorithms, HeartLogic and TriageHF, in cardiac implantable electronic devices (CIEDs) to alert remote healthcare professionals to suspected worsening of ...
ISSAQUAH, Wash.--(BUSINESS WIRE)--BaroPace Inc. announces its Phase I first-in-human trial of PressurePace TM, its patent-pending pacemaker control algorithm for the treatment of heart failure with ...
The American College of Cardiology has published a new update to its consensus decision pathway for the treatment of heart failure with reduced ejection fraction (HFrEF). Chair of the consensus ...
LISBON, Portugal—The results are mixed when it comes to the application of guideline-directed medical therapy (GDMT) for the treatment of heart failure (HF), two new studies have found, with one ...
Panelists discuss how effective heart failure management requires collaborative care across multiple specialties (primary care, cardiology, endocrinology, nephrology) with advanced practice providers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback